NUCLEATRON
LIVE

Serial Number

99442853

Owner

C-Gen.AI Corp.

Attorney

John M. Kim

Filing Date

Oct 14, 2025

Add to watchlist:

No watchlists yet
View on USPTO

NUCLEATRON Trademark

Serial Number: 99442853

NUCLEATRON is a trademark filed by C-Gen.AI Corp. on October 14, 2025. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

C-Gen.AI Corp. (2 trademarks)

800 W El Camino Real, Suite 180
Mountain View, CA 94040

Entity Type: 03

Trademark Details

Filing Date

October 14, 2025

Registration Date

Not Registered

Published for Opposition

April 28, 2026

Goods & Services

Providing temporary use of on-line non-downloadable software for deploying, managing, integrating, optimizing, monetizing, and scaling artificial intelligence (AI) infrastructures and workloads; Providing temporary use of on-line non-downloadable software for deploying, managing, integrating, optimizing, monetizing, and scaling artificial intelligence (AI), machine learning, cloud computing, digital transformation, and data processing applications; Providing temporary use of on-line non-downloadable software for managing distributed computing resources across multiple cloud environments; Technological planning and consulting services in the field of artificial intelligence, cloud computing, and software development; Computer programming services; Providing computer software design, development, implementation, and maintenance; IT integration services; technical support, namely, troubleshooting of computer software problems

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 23, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 28, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 28, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 22, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 1, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 1, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 1, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 1, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 24, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 3, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 3, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 3, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 3, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 17, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Oct 14, 2025 MAFR
NEW APPLICATION ENTERED
Oct 14, 2025 NWAP

Related Trademarks

More in Same Class

AMPHION

AMPHION

C A I P M CERTIFIED ARTIFICIAL INTELLIGENCE PROGRAM MANAGER logo

C A I P M CERTIFIED ARTIFICIAL INTELLIGENCE PROGRAM MANAGER

SOFTWARE AS A SERVICE (SAAS) AND PLATFORM AS A SERVICE (PAAS) FEATURING ARTIFICIAL INTELLIGENCE SOFTWARE AND CLOUD-BASED PLATFORMS FOR USE IN MEDICAL DIAGNOSTICS, HEALTHCARE DATA ANALYSIS, DISEASE DETECTION, AND CLINICAL DECISION SUPPORT; PROVIDING TEMPORARY USE OF NON-DOWNLOADABLE SOFTWARE FOR ANALYZING GENOMIC, PROTEOMIC, METABOLOMIC, TRANSCRIPTOMIC, AND MULTI-OMICS DATA TO SUPPORT PRECISION MEDICINE AND PERSONALIZED HEALTHCARE; PROVIDING ONLINE NON-DOWNLOADABLE SOFTWARE USING MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE FOR BIOINFORMATICS, BIOLOGICAL DATA INTERPRETATION, BIOMARKER DISCOVERY, DRUG TARGET IDENTIFICATION, AND DRUG DISCOVERY; SCIENTIFIC AND TECHNOLOGICAL RESEARCH SERVICES IN THE FIELDS OF BIOTECHNOLOGY, LIFE SCIENCES, HEALTHCARE, AND ARTIFICIAL INTELLIGENCE, NAMELY, RESEARCH AND DEVELOPMENT OF DIAGNOSTIC METHODS, THERAPEUTIC STRATEGIES, AND BIOPHARMACEUTICAL TECHNOLOGIES; DESIGN, DEVELOPMENT, AND HOSTING OF CLOUD-BASED PLATFORMS FOR BIOMEDICAL DATA INTEGRATION, COMPUTATIONAL BIOLOGY, PREDICTIVE ANALYTICS, AND CLINICAL RESEARCH COLLABORATION.

SOFTWARE AS A SERVICE (SAAS) AND PLATFORM AS A SERVICE (PAAS) FEATURING ARTIFICIAL INTELLIGENCE SOFTWARE AND CLOUD-BASED PLATFORMS FOR USE IN MEDICAL DIAGNOSTICS, HEALTHCARE DATA ANALYSIS, DISEASE DETECTION, AND CLINICAL DECISION SUPPORT; PROVIDING TEMPORARY USE OF NON-DOWNLOADABLE SOFTWARE FOR ANALYZING GENOMIC, PROTEOMIC, METABOLOMIC, TRANSCRIPTOMIC, AND MULTI-OMICS DATA TO SUPPORT PRECISION MEDICINE AND PERSONALIZED HEALTHCARE; PROVIDING ONLINE NON-DOWNLOADABLE SOFTWARE USING MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE FOR BIOINFORMATICS, BIOLOGICAL DATA INTERPRETATION, BIOMARKER DISCOVERY, DRUG TARGET IDENTIFICATION, AND DRUG DISCOVERY; SCIENTIFIC AND TECHNOLOGICAL RESEARCH SERVICES IN THE FIELDS OF BIOTECHNOLOGY, LIFE SCIENCES, HEALTHCARE, AND ARTIFICIAL INTELLIGENCE, NAMELY, RESEARCH AND DEVELOPMENT OF DIAGNOSTIC METHODS, THERAPEUTIC STRATEGIES, AND BIOPHARMACEUTICAL TECHNOLOGIES; DESIGN, DEVELOPMENT, AND HOSTING OF CLOUD-BASED PLATFORMS FOR BIOMEDICAL DATA INTEGRATION, COMPUTATIONAL BIOLOGY, PREDICTIVE ANALYTICS, AND CLINICAL RESEARCH COLLABORATION.

EON 2LIFE logo

EON 2LIFE

PAPERMOON

PAPERMOON

AURASCAPE AURI

AURASCAPE AURI